e-therapeutics (LON:ETX) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

e-therapeutics plc (LON:ETX) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 10.04 ($0.13) and traded as low as GBX 9 ($0.12). e-therapeutics shares last traded at GBX 9 ($0.12), with a volume of 2,518,125 shares.

e-therapeutics Stock Performance

The company has a debt-to-equity ratio of 0.33, a current ratio of 22.20 and a quick ratio of 20.13. The stock has a fifty day simple moving average of GBX 9 and a two-hundred day simple moving average of GBX 10.04. The firm has a market capitalization of £52.59 million, a P/E ratio of -450.00 and a beta of 0.46.

e-therapeutics Company Profile

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.